Navigation Links
Marlo Thomas and St. Jude Children's Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season
Date:11/19/2007

"

Because of the pioneering treatments developed at St. Jude, the survival rate for acute lymphoblastic leukemia, the most common form of childhood cancer, has risen from 4 percent when the hospital opened in 1962 to more than 90 percent today. The research and treatment protocols developed at St. Jude are freely shared with the scientific community and used by hospitals across the nation and around the world.

Thanks and Giving is a national fund-raising and awareness campaign created by Marlo Thomas and her siblings, Terre and Tony Thomas, the children of hospital founder Danny Thomas. In the spirit of their father, they have once again called on St. Jude's cherished celebrity family, all of whom donated their time and talents for new national television spots produced by Tony Thomas which will air on broadcast and cable networks, in both general and Spanish-language markets. The Thanks and Giving campaign will also feature Internet banner ads that will run on thousands of sites, including nfl.com, AOL.com and Yahoo!; and a 60-second movie trailer, which will once again reach millions of moviegoers on more than 20,000 movie screens nationwide and on American Airlines flights during the holidays. Radio spots featuring country artist Keith Urban will run on hundreds of stations across the nation throughout the campaign. The national media blitz also includes print ads in leading magazines and newspapers in 20 major markets and USA Today. The online visibility encompasses banner ads on more than 3,000 Web sites and spectacular outdoor advertising from coast to coast.

More information is available at http://www.stjude.org, where visitors can view the celebrity spots, learn about the corporate partners, buy unique merchandise designed by the patients of St. Jude, and meet some of the patients.

Corporate Partner Quotes

Executives from leading Thanks and Giving partners offer insight into the
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
5. MDS to Present at Thomas Weisel Partners Healthcare Conference
6. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Mediware Names Thomas K. Mann Chief Executive Officer
9. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
10. Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
11. Canary Foundation and the Thomas G. Labrecque Foundation Launch a New Lung Cancer Early Detection Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...swire-FirstCall/ -- Inverness Medical Innovations,...atient diagnostics, monitoring and health manageme...ce President, Finance, will attend the upcoming RB... held December 10-11, 2008 at the Westin Times Squ... is scheduled for Thursday, December 11, 2008 at ...
(Date:12/4/2008)...d ,idiosyncratic, study finds , , THURS...accine designed to protect against cervical cancer... doses. , That,s the assessment of Australian r...00 doses of the Gardasil vaccine were given to gir..., Gardasil protects against four types of human...
(Date:12/4/2008)...e-USNewswire/ -- Stem cells derived from bone marr...t a disease called epidermolysis bullosa (EB), a d...kin, according to a study pre-published online in ...ety of Hematology. , , Epidermolysis bullo...fragile skin and blistering on touch, akin to thir...
(Date:12/4/2008)...e/ -- Pittsburgh-based Foundation Radiology,Group... to be one of the 50,largest radiology groups in ...,Pittsburgh, FRG has been growing at a brisk pace...eaders and national experts. , In a little ...44th out of,50 nationally, proof that their busin...
Breaking Medicine News(10 mins):Health News:Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008 2Health News:Cervical Cancer Vaccine Well Tolerated 2Health News:Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option for Skin Disorder 2Health News:Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option for Skin Disorder 3Health News:Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option for Skin Disorder 4Health News:Foundation Radiology Group Named One of 50 Largest Radiology Groups in the Country 2
...d with good health and vitality. However, just a s...manufacture vitamin D. //It doesn't take much sunl...nly far less than it takes to get a suntan. Recent...rstand the complex motivations involved with UV li...
...Edward Romond reported from two separate trials th...effectively treated with Herceptin therapy using t...ished in the journal The New England Journal of Me... clinical trials, which compared patients getting ...
...search team from Kyoto University have found that ...hances of getting common cold.// The results of th...l of Preventive Medicine. The study was conducted...tween the age group of 18 to 65. The study recrui...
...ply of deceased donor kidneys for transplantation....donor kidney transplants.// A recent paper in the...the insufficient supply of transplantable kidneys,...increase the number of living donor renal transpla...
Other Medicine News:Health News:Trastuzumab therapy effective for Breast cancer patients with Her-2/neu positive 2Health News:Daily Gargling May Prevent Common Colds 2Health News:Strategies To Boost Living Donor Kidney Transplants 2
(Date:12/4/2008)...o Advance to Clinical Trials , , SAN DIEGO,...nc., a biopharmaceutical company focused on the de...nists for the treatment of cancer, respiratory and...initiated a Phase I clinical trial of VTX-2337, a .... The multi-center clinical trial is being conduc...
(Date:12/3/2008)...irstCall/ -- Sangamo BioSciences, Inc.,(Nasdaq: ... update on milestones,achieved in 2008 and previe...and Analyst Briefing to be held in New York City t...a-Aldrich Corporation,s Research,Biotech Business...tial of the,two companies, collaboration to comme...
(Date:12/3/2008)...wswire-FirstCall/ -- Isis Pharmaceuticals,Inc. (...armaceuticals, Inc.,provided positive survival re...,OGX-011 in combination with docetaxel and prednis... prednisone alone ("the control arm") for first-li...state cancer. The current 10.6,month median over...
(Date:12/2/2008)...wswire-FirstCall/ -- Biopure Corporation,(Nasdaq:...cal Research Center,(NMRC) has submitted to the F...tigational new drug (IND) application to conduct a...ic Hemopure(R) [hemoglobin glutamer - 250 (bovine)...rauma patients. The study is,entitled "Operation ...
Breaking Medicine Technology:VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 4Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 5Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 6Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Methods and Tools Used to Achieve Best Customer Satisfaction 21500 1Methods and Tools Used to Achieve Best Customer Satisfaction 21500 2Miami Institute Launches New Weight Loss Program 21496 1Miami Institute Launches New Weight Loss Program 21496 2Amick Shaw Join S C BlueCross Foundation Board 21492 1Study 3A Quick responses to influenza outbreaks reduces illness and death 21490 1Study 3A Quick responses to influenza outbreaks reduces illness and death 21490 2
...IRE)--Jun 12, 2007 - Results from the,successful c...,OSCI) FACTIVE(R) (gemifloxacin mesylate) tablets ...neumonia of mild to moderate,severity (CAP) have b...ed Journal of Antimicrobial Chemotherapy, currentl...Phase III clinical,trial comparing a five-day and ...
...WIRE)--Jun 12, 2007 - Proprietary Pulsed,Electroma...,Technologies, Inc. (AMEX:II), improved neuron sur...lammation, researchers,reported today in a platfor...(BEMS,http://www.bioelectromagnetics.org) Annual ...iated with neuron death that occurs in,Parkinson,s...
Other Medicine Technology:July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 2July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 3July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 4July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia 5Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 2Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds 3
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: